申请人:Pacific Corporation
公开号:US06492416B1
公开(公告)日:2002-12-10
The present invention provides a novel class of 4,5-diaryl-3(2H)-furanone derivatives, which inhibit strongly and selectively COX-2 over COX-1. They are useful to treat inflammation, inflammation-associated disorders, and COX-2 mediated diseases.
本发明提供了一类新型的4,5-二芳基-3(2H)-呋喃酮衍生物,其强烈且选择性地抑制COX-2而不抑制COX-1。它们可用于治疗炎症、与炎症相关的疾病和COX-2介导的疾病。